FDA Approves Nivolumab for Bladder Cancer

The FDA has approved nivolumab for the treatment of unresectable locally advanced or metastatic bladder cancer that worsened after treatment with platinum-based chemotherapy.

Cancer Currents: An NCI Cancer Research Blog